CEL-SCI Corporation CVM

V, your post is the likely future of CVM. Merck will buy them for $40 instead of the $140 ticket price you will see with an IPO

How many of you know that both Opdivo and Keytruda are both approved for head and neck cancer patients that fail Conventional chemotherapy? The FDA has exhibited how corrupt they are by suppressing the use of effective treatments, like ivermectin and promoting a flawed, clearly dangerous Covid vax. Don’t think this corruption doesn’t extend to other therapeutics as well. Big Pharma will do whatever it takes to protect their franchise drugs. Nothing else explains why a non-toxic therapy for a fatal disease with proven efficacy has taken so long to get approval.

This is a $200 stock with US approval which is the pot of gold long term shareholders have been waiting for - not a $40 buyout.

I will tell you why, Ted. The FDA is just another corrupt government 3 later agency. They are wholly owned by big pharma. Why else would the recommend a toxic COViD vax for children when it is known it does NOT prevent transmission and in this age group the potential complications are far worse than the minuscule benefits in this age group. The FDA is not on the side of life and health - otherwise MK would have been already approved. CVM - perhaps with the blessing of their CEO - is being bled dry of funds to facilitate a fire sale to big pharma. This is a $200 stock that will be sold for $20-$30..

Only a reckless fool would stay short -at least near term - on CVM based on this recent application.

Right on Anthony. Finally someone besides me recognizing how corrupt the FDA is. If the letterhead said Pfizer on the application Multikine would already be approved.

People criticizing trial results and algorithms simply do not get cancer treatment. SCCa of H&N has been treated the same for decades. There are no real new treatments or groundbreaking drugs - until Multikine. 40% improvement in 5 year survival is unheard of for this disease. Any survival benefit in light of its ZERO TOXICITY should have led to approval. I guarantee you if Pfizer owned this it would have been approved a year ago. What if Geert has been paid off by big pharma to drag and delay so CVM can be acquired at a huge discount? Geert will still make more than he could ever spend a get a cushy spot with the acquirer
a cushy position by the acquirer.

There is something very wrong here. There should be far more interest in multikine given positive survival results and ZERO toxicity. The technology alone should be worth $20/s buyout. Board should have acted against CEO by now.

Geert needs to go. He is doing nothing for shareholders. Positive results with orphan drug and still nowhere near approval. Shareholders should not tolerate this level of inaction.

For those of you who think the FDA is not doing the bidding of big pharma and wonder why an effective and life saving treatment from a SMALL company is being delayed

https://youtu.be/rmxUsAI29fw